Limb-girdle Muscular Dystrophy Type 2I - 1 Studies Found
| RECRUITING |
: Study to Evaluate the Efficacy and Safety of BBP-418 (Ribitol) in Patients With Limb Girdle Muscular Dystrophy 2I (LGMD2I) : Limb-Girdle Muscular Dystrophy Type 2I (LGMD2I) : 2024-11-21 : The BBP-418 drug product is provided as Granules for Oral solution consisting of BBP-418 drug substance and silicon dioxide in a multilaminate sachet |